|
Ezetimibe/simvastatin outdoes statin alone for lowering CRP.(C-reactive protein)
Publication: Internal Medicine News Publication Date: 15-JUN-06 Author: Jancin, Bruce
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2006 International Medical News Group
ATLANTA -- The ezetimibe/simvastatin combination pill Vytorin has a markedly greater anti-inflammatory effect, as reflected by reduction of C-reactive protein, than either agent alone, Dr. Christie M. Ballantyne said at the annual meeting of the American College of Cardiology.
It's already established that Vytorin produces greater LDL reductions than does statin monotherapy. To learn more about the...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Internal Medicine News |
Ezetimibe/simvastatin combo safe, effective in kidney disease.(Disease...
June 15, 2006
|
Enoxaparin beats heparin as adjunct in acute MI.(Myocardial infarction...
June 15, 2006
|
Bosentan label changes address hepatotoxicity.(Brief article)
June 15, 2006
|
Atherothrombosis linked to major CV events.(Cardiovascular )(Disease/D...
June 15, 2006
|
Drug interactions with warfarin often serious: warfarin tops the list ...
June 15, 2006
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
